Avanos Medical, Inc.
AVNS
$12.47
$0.040.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 687.80M | 681.50M | 682.40M | 680.10M | 673.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 687.80M | 681.50M | 682.40M | 680.10M | 673.30M |
| Cost of Revenue | 306.50M | 303.20M | 301.50M | 297.00M | 293.60M |
| Gross Profit | 381.30M | 378.30M | 380.90M | 383.10M | 379.70M |
| SG&A Expenses | 321.40M | 310.20M | 314.20M | 331.70M | 340.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.00M | 2.70M | 4.30M | 2.30M | 3.30M |
| Total Operating Expenses | 643.30M | 628.80M | 631.60M | 643.10M | 649.90M |
| Operating Income | 44.50M | 52.70M | 50.80M | 37.00M | 23.40M |
| Income Before Tax | -403.30M | 26.10M | 14.00M | 2.70M | -7.90M |
| Income Tax Expenses | -17.00M | 4.40M | 7.00M | 4.30M | 2.00M |
| Earnings from Continuing Operations | -386.30 | 21.70 | 7.00 | -1.60 | -9.90 |
| Earnings from Discontinued Operations | -5.80M | -6.00M | 700.00K | -60.60M | -51.90M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -392.10M | 15.70M | 7.70M | -62.20M | -61.80M |
| EBIT | 44.50M | 52.70M | 50.80M | 37.00M | 23.40M |
| EBITDA | 90.00M | 98.60M | 93.40M | 79.80M | 66.90M |
| EPS Basic | -8.52 | 0.34 | 0.17 | -1.33 | -1.32 |
| Normalized Basic EPS | 0.51 | 0.61 | 0.57 | 0.34 | 0.15 |
| EPS Diluted | -8.54 | 0.33 | 0.16 | -1.33 | -1.32 |
| Normalized Diluted EPS | 0.50 | 0.61 | 0.56 | 0.34 | 0.15 |
| Average Basic Shares Outstanding | 184.10M | 184.30M | 185.10M | 186.00M | 186.40M |
| Average Diluted Shares Outstanding | 185.60M | 186.20M | 186.40M | 186.90M | 186.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
